NCT06141785

Brief Summary

The goal of this intervention study is to study the effect of nutritional interventions in patients with cancer receiving palliative chemotherapy. The main question it aims to answer is: Does early nutritional interventions affect body weight, quality of life, survival, muscle mass, performance status, physical function, nutritional risk and treatment tolerance in patients with cancer receiving palliative chemotherapy? Researchers will compare patients receiving the intervention to a historical control cohort following current clinical practice.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Jun 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jun 2024Jan 2027

First Submitted

Initial submission to the registry

November 7, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 21, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 29, 2027

Expected
Last Updated

December 24, 2025

Status Verified

August 1, 2025

Enrollment Period

1.8 years

First QC Date

November 7, 2023

Last Update Submit

December 17, 2025

Conditions

Keywords

Nutritional interventionsDieteticsCancerMalnutritionNutrition

Outcome Measures

Primary Outcomes (1)

  • Body weight

    Change in body weight in kilogram

    baseline, week 12 (±2 weeks), week 24 (±2 weeks)

Secondary Outcomes (11)

  • Self reported Quality of life

    baseline, week 12 (±2 weeks), week 24 (±2 weeks)

  • Survival

    one year after initiation

  • Muscle mass

    baseline and week 24 (±2 weeks)

  • Performance status

    baseline, week 12 (±2 weeks), week 24 (±2 weeks)

  • Hand grip strength

    baseline, week 12 (±2 weeks), week 24 (±2 weeks)

  • +6 more secondary outcomes

Study Arms (2)

Nutritional Intervention

EXPERIMENTAL

Patients with Cancer treated with palliative chemotherapy.

Other: Nutritional intervention

Historical control

NO INTERVENTION

Patients with Cancer treated with palliative chemotherapy. Historical Control cohort following current clinical practise, where nutritional treatment is not systematically implemented but patients can be referred to a clinical dietitian after clinical assessment by the treating physician or nurse.

Interventions

An individually targeted nutritional intervention, and a simple home-based physical exercise program. The Nutritional intervention will be delivered by a clinical dietitian, from treatment initiation and throughout the treatment trajectory

Nutritional Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who are newly diagnosed with lung, colorectal, ovarian, or pancreatic cancer.
  • patients treated with first-line palliative chemotherapy
  • patients who are Danish speaking
  • patients ≥18 years of age
  • patients who are cognitive well-functioning

You may not qualify if:

  • Patients not using electronic mail
  • patients with dementia
  • patients not able to comply with the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gødstrup Hospital

Herning, 7400, Denmark

RECRUITING

MeSH Terms

Conditions

NeoplasmsMalnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Therese Ovesen, Prof

    University Clinic for Flavour, Balance and Sleep

    STUDY DIRECTOR

Central Study Contacts

Kirstine Guld Frederiksen, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Intervention with a historical control cohort.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

November 7, 2023

First Posted

November 21, 2023

Study Start

June 1, 2024

Primary Completion

March 31, 2026

Study Completion (Estimated)

January 29, 2027

Last Updated

December 24, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations